Related content

Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy

By Hansen Bettina Dencker   Schmidt Henrik   von der Maase Hans   Sjoegren Pia   Agger Ralf   Hokland Marianne  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 400-405

Informa Healthcare

Access to resources Recommend Favorite

Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite

Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype

By Varney Michelle   Li Aihua   Dave Bhavana   Bucana Corazan   Johansson Sonny   Singh Rakesh  

Clinical and Experimental Metastasis, Vol. 20, Iss. 8, 2003-12 ,pp. : 723-731

Springer Publishing Company

Access to resources Recommend Favorite

Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine

By Molnár E.L.   Hegyesi H.   Tóth S.   Darvas Z.   László V.   Szalai C.   Falus A.  

Seminars in Cancer Biology, Vol. 10, Iss. 1, 2000-02 ,pp. : 25-28

Academic Press

Access to resources Recommend Favorite